Fundraising Fox
Route 92 Medical
San Mateo, US · Founded 2015 · Delaware corporation · 202 employees on LinkedIn · 8 known investors
Find your way into Route 92 Medical
Sign up to see every warm intro you have to Route 92 Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Route 92 Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment. Its products are designed to navigate tortuous vascular anatomy and reach target locations for procedures such as aspiration.
Founders & leadership
Route 92 Medical was founded in 2015 by Dr. Chou.
Board
Investors · 8
How we know: the company's own site · press coverage · funding news · Not right? Tell us
How we know: the company's own site · board seat on SEC Form D · press coverage · funding news · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · press coverage · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Runway Growth Capital's portfolio page · Not right? Tell us
How we know: US Venture Partners's portfolio page · a partner's Signal profile · press coverage · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$208.1M disclosed across 8 rounds · 2016–2026
▶$50MraisedApr 2026 · 11 investors · Other Health CareRule 506(b)
- Tony M. ChouExecutive Officer, Director
- Ariella GolombDirector
- John MillerExecutive Officer
- Noel JeeDirector
- Jonathan RootDirector
- Jack W. LasersohnDirector
- J. Patrick MackinDirector
- Mitchell HillDirector
- Cindy LynchExecutive Officer
- Lucas BuchananDirector
- Randall SullivanExecutive Officer
- Kirsten ValleyExecutive Officer
- Chris HartmanExecutive Officer
- Casper de ClercqDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50.4MraisedJul 2024 · 5 investors · Other Health CareRule 506(b)
- Tony ChouExecutive Officer, Director
- Jack LasersohnDirector
- Tamir MeiriDirector
- Jonathan RootDirector
- Cindy LynchExecutive Officer
- Ariella GolombDirector
- Noel JeeDirector
- Casper de ClercqDirector
- Offering amount
- $50.4M
- Amount sold
- $50.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31.3MraisedNov 2023 · 4 investors · Other Health CareRule 506(b)
- Jack LasersohnDirector
- Cindy LynchExecutive Officer
- Jonathan RootDirector
- Tony ChouExecutive Officer, Director
- Casper de ClercqDirector
- Ariella GolombDirector
- Offering amount
- $31.3M
- Amount sold
- $31.3M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$46.9MraisedJul 2021 · 4 investors · Other Health CareRule 506(b)
- Tony ChouExecutive Officer, Director
- Ariella GolombDirector
- Jonathan RootDirector
- Jack LasersohnDirector
- Casper de ClercqDirector
- Cindy LynchExecutive Officer
- Offering amount
- $61M
- Amount sold
- $46.9M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedMay 2019 · 2 investors · Other Health CareRule 506(b)
- Tony ChouExecutive Officer, Director
- Jonathan RootDirector
- Casper de ClercqDirector
- John E. RunnellsExecutive Officer
- Jack LasersohnDirector
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedAug 2018 · 1 investors · Other Health CareRule 506(b)
- John E. RunnellsExecutive Officer
- Jack LasersohnDirector
- Tony ChouExecutive Officer, Director
- Jonathan RootDirector
- Offering amount
- $6.7M
- Amount sold
- $4.7M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedMay 2017 · 1 investors · Other Health CareRule 506(b)
- Tony ChouExecutive Officer, Director
- Offering amount
- $5.9M
- Amount sold
- $5.9M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedMay 2016 · 1 investors · BiotechnologyRule 506(b)
- Tony ChouExecutive Officer, Director
- John E. RunnellsExecutive Officer
- Jonathan RootDirector
- Jack LasersohnExecutive Officer, Director
- Offering amount
- $5.9M
- Amount sold
- $5.9M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Route 92 Medical do?
- Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment. Its products are designed to navigate tortuous vascular anatomy and reach target locations for procedures such as aspiration.
- Who founded Route 92 Medical?
- Route 92 Medical was founded by Dr. Chou in 2015.
- Who are Route 92 Medical's investors?
- Route 92 Medical's investors include Novo Holdings, The Vertical Group, Norwest Venture Partners, Runway Growth Capital, US Venture Partners, Sectoral Asset Management, Sofinnova Ventures, U.S. Venture Partners.
- How much funding has Route 92 Medical raised?
- Route 92 Medical has disclosed $208.1M raised across 8 rounds.
- Where is Route 92 Medical headquartered?
- Route 92 Medical is headquartered in San Mateo, US.